The global Antiseptic and Disinfectants market size was estimated at USD 48 billion in 2021 and is expected to surpass around USD 69 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.11% during the forecast period 2022 to 2030.
Key Takeaways:
An increase in the prevalence of diseases such as typhoid, cholera, hepatitis A, food poisoning, and dengue, primarily due to lack of home cleanliness, is one of the major factors expected to drive market growth. For instance, as per a report published by WHO in 2022, Over the last two decades, the number of dengue cases reported to WHO has surged by more than 8-fold, from 505,430 cases in 2000 to over 4.4 million in 2010, and 7.2 million in 2020. Such diseases are mainly caused by viruses, bacteria, and germs, which thrive in unhealthy home environments and unhygienic toilets, latrines, and kitchens.
Key factors driving the market expansion include technological advancements in antiseptics and disinfectants along with increasing use of endoscope reprocessors and surgical units. The current COVID-19 outbreak is expected to have a substantial impact on the market. The pandemic has resulted in a significant surge in demand for emergency supplies, hospital equipment, medicines, and medical disposables. According to Eurostat in 2020, extra-EU exports and imports of COVID-19 related products increased by 5.5 % and 10.4 % respectively, compared to 2019.
Additionally, EU extra- imports of protective oxygen and garments equipment recorded the highest increase (respectively by 38.7% and 40.3 % compared with 2019) amongst COVID-19 related products, followed by sterilization products (19.1 %) and. diagnostic equipment (19.2 %). However, the highest increases for EU- extra- exports were recorded for diagnostic testing equipment (14.9%), and sterilization products (16.0 %). As a result, market growth is expected to accelerate in the near future. Furthermore, the global market for antiseptics and disinfectants is consolidating due to the rising popularity of medical equipment along with the increased research collaboration and agreements between diverse manufacturers. For instance, in June 2021, Bactiguard and Schülke & Mayr GmbH, a German company, agreed to distribute Bactiguard's wound care solutions exclusively to German hospitals. The agreement allows schülke to add Bactiguard's hypochlorous acid-based portfolio to its existing antiseptic and wound-care product line which will, in turn, push the market scale during the study period.
Report Scope of the Antiseptic and Disinfectants Market
Report Coverage |
Details |
Market Size in 2022 |
USD 49.98 Billion |
Market Size by 2030 |
USD 69 Billion |
Growth Rate from 2022 to 2030 |
CAGR of 4.11% |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Type, Product, Sales Channel, End User and Geography |
Companies Mentioned |
Steris Plc, Kimberly-Clark Corporation, 3M, eckitt Benckiser, Bio-Cide International, Inc., Johnson & Johnson, Cardinal Health, BD |
Type Insights
Based on type, the quaternary ammonium compounds segment held the largest revenue share of 31.6% in 2021 and is expected to witness considerable growth over the forecast period. Quaternary ammonium compounds are widely used as surface disinfectants in hospitals and laboratories. These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics. In addition, it is also used for disinfecting medical equipment that comes into direct contact with skin. The rising incidence of hospital-acquired infections across the globe is likely to positively impact the segment growth. For instance, as per WHO, every year, 7 out of every 100 hospitalized patients in industrialized nations and 10 out of every 100 hospitalized patients in underdeveloped countries acquire at least one healthcare-associated infection.
The enzyme segment is anticipated to witness the fastest growth rate over the forecast period. Generally, enzyme-based antiseptics and disinfectants are used to control odors that are created by chemical processes. It is also commonly used in research facilities for cleaning enzyme-based or catalyst-based products. It's used to clean testing kits in hospitals and clinics. The demand for these items is predicted to rise as the number of research facilities grows as a result of increased R&D spending around the world. For instance, as per Congressional Research Service, globally, total global R&D spending has more than tripled in current dollars since 2000, rising from $677 billion to $2.2 trillion in 2019, which is expected to boost the number of research laboratories owing to which segment is anticipated to grow over the forecast period.
Product Insights
The medical device disinfectants segment held the largest revenue share of 45.8% in 2021. Medical device disinfectants are generally used for reprocessing surgical units and endoscopes. Glutaraldehyde, phenol/phenate, hydrogen peroxide, and peracetic acid are some of the disinfectants used for reprocessing/disinfection of medical devices. Proper reprocessing of medical devices and endoscopes is essential as they transmit infection from one patient to another due to direct contact with skin. The increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period.
The enzymatic cleaners segment is anticipated to witness the fastest growth rate over the forecast period. Enzymatic cleaners are more efficient on bacterial surfaces and are commonly used to avoid odor. It's commonly used to disinfect testing kits and surgical equipment in clinics and hospitals. The number of surgical procedures and the amount of hospital-acquired illnesses are two important variables driving the industry. Non-pathogenic beneficial microorganisms in enzyme cleaners are effective at displacing disease-causing germs without causing any side effects. The residue of certain antiseptics and disinfectants can sometimes cause harm to humans. In such cases, enzymatic cleaners are used. Hence, the segment is anticipated to grow over the forecast period.
Sales Channel Insights
The B2B segment dominated the market for antiseptics and disinfectants and held the largest revenue share of 65.5% in 2021. In the B2B sales channel, companies directly sell their products to businesses and not to consumers. B2B sales channels usually have longer sales cycles and higher-order values. B2B sales channel is expected to witness a low growth rate during the forecast period owing to entry barriers in the B2B business, which include a lack of investment to develop technologically advanced products and challenges pertaining to coordinating with various vendors. Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics and disinfectants marketed under the B2B sales channel. Hospitals, clinics, healthcare providers, and suppliers are major end-users of the B2B sales channel.
The FMCG distribution channel comprises three major entities: agents, facilitators, and merchants. Agents generally generate sales by promoting the products of the company. Agents can be a member of the company or independent individuals. Facilitators are generally involved in the transportation of manufactured goods from one place to another. Warehouse owners, logistic services, and independent types are included under the facilitator’s category. Wholesalers and retailers are generally categorized under the merchant’s category. Consumers generally purchase FMCG products directly from retailers and wholesalers. Hand sanitizers, antiseptic topical creams, antiseptic washes, and antiseptics wipes are categorized under the FMCG product line. 3M, Lifebuoy, Dettol, and Purell are some of the notable brands of hand sanitizers. Nufree Finipil Pro Elec Antiseptic Cream, Tea Tree Therapy Antiseptic Cream, and Neosporin are some of the notable antiseptics topical cream brands marketed as FMCG products.
End-use Insights
The hospital segment dominated the market for antiseptics and disinfectants and accounted for a revenue share of 46.4% in 2021. The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. For instance, as per CDC, every day, around 1 out of every 31 hospital patients contracts a hospital-acquired infection. The use of appropriate disinfectants and antiseptics is critical in reducing the spread of illnesses. Furthermore, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for antiseptics and disinfectants is also expected to increase. For instance, as per Eurostat, Germany, and France, had the highest healthcare expenditure (around 11.8%) in GDP in 2019. Thus, such factors are expected to propel segment growth over the forecast period.
Over the forecast period, the increasing number of surgical procedures and hospitals will be important drivers of the segment's growth. To maintain a healthy atmosphere in the clinic, basic sanitation and hygiene are required. Additionally, an increase in the number of hospital-acquired infections may increase the demand for antiseptics and disinfectants. Therefore, the segment is expected to grow over the forecast period.
Regional Insights
North America dominated the antiseptics and disinfectants market and accounted for a revenue share of around 34.5% in 2021. The growing number of healthcare personnel conducted in North America and the increasing number of surgeries are the factors predicted to increase the demand for disinfectants and antiseptics in the region. Antiseptic and disinfectant solutions are necessary for surgical procedures and research because they limit the danger of contamination and infection transmission from one patient to the next. Furthermore, as doctors encourage the use of disinfection treatments, an increase in the number of hospital-acquired illnesses may drive up the demand for such solutions. As a result, these factors are projected to drive market expansion throughout the forecast period.
The increasing incidence of healthcare-associated infections, food poisoning, cholera, and typhoid fever is a major factor driving the market over the forecast period. In addition, rising awareness about home cleanliness among people is likely to positively impact the market growth. Furthermore, major players are also making efforts to enter untapped markets in the Asia Pacific region, thereby expanding the market scope.
Some of the prominent players in the Antiseptic and Disinfectants Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Antiseptic and Disinfectants market
By Type
By Product
By Sales Channel
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Antiseptic and Disinfectants Market Study: